Allakos Inc • ALLK

Capital at risk.

About Allakos Inc
Ticker
info
ALLK
Trading on
info
NASDAQ
ISIN
info
US01671P1003
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Robert Alexander Ph.D.
Headquarters
info
825 Industrial Road, San Carlos, CA, United States, 94070
Employees
info
0
Website
info
allakos.com
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Metrics
BasicAdvanced
Market cap
info
$22.7M
P/E ratio
info
-
EPS
info
-$1.30
Dividend Yield
info
0.00%
Beta
info
0.71
Forward P/E ratio
info
0
EBIDTA
info
$-115M
Ex dividend date
info
-
Price & volume
Market cap
info
$22.7M
Average daily volume
info
0.7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0.29
Earnings
EPS
info
-$1.30
EPS estimate (current quarter)
info
-$0.18
EPS estimate (next quarter)
info
-$0.30
EBITDA
info
$-115M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.71
52-week High
info
$1.56
52-week Low
info
$0.23
50-day moving average
info
$0.44
200-day moving average
info
$0.81
Short ratio
info
0.72
Short %
info
3.08%
Management effectiveness
ROE (TTM)
info
93.54%
ROA (TTM)
info
43.64%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
90.2M
Float
info
59M
Insiders %
info
2.05%
Institutions %
info
91.64%
Analyst Insights & forecasts
info

34% Buy

66% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$0.35
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.81
-$0.47
72.34%
Q1 • 24Beat
-$0.30
-$0.33
9.09%
Q2 • 24Beat
-$0.21
-$0.25
16.00%
Q3 • 24Beat
-$0.26
-$0.18
46.00%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-18.4M
∞%
Q3 • 24
$0M
$0.4M
∞%
Q4 • 24
NaN%
102.05%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$124M
$51.7M
41.54%
Q3 • 24
$96.6M
$17.8M
18.41%
Q4 • 24
22.37%
65.60%
55.68%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-31.7M
$15.6M
$0M
$-31.7M
Q3 • 24
$-12.5M
$19.8M
$0M
$-12.5M
Q4 • 24
60.55%
27.11%
100.00%
60.59%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Allakos Inc share?
Collapse

Allakos Inc shares are currently traded for undefined per share.

How many shares does Allakos Inc have?
Collapse

Allakos Inc currently has 90.2M shares.

Does Allakos Inc pay dividends?
Collapse

No, Allakos Inc doesn't pay dividends.

What is Allakos Inc 52 week high?
Collapse

Allakos Inc 52 week high is $1.56.

What is Allakos Inc 52 week low?
Collapse

Allakos Inc 52 week low is $0.23.

What is the 200-day moving average of Allakos Inc?
Collapse

Allakos Inc 200-day moving average is $0.81.

Who is Allakos Inc CEO?
Collapse

The CEO of Allakos Inc is Dr. Robert Alexander Ph.D..

How many employees Allakos Inc has?
Collapse

Allakos Inc has 0 employees.

What is the market cap of Allakos Inc?
Collapse

The market cap of Allakos Inc is $22.7M.

What is the P/E of Allakos Inc?
Collapse

The current P/E of Allakos Inc is null.

What is the EPS of Allakos Inc?
Collapse

The EPS of Allakos Inc is -$1.30.

What is the PEG Ratio of Allakos Inc?
Collapse

The PEG Ratio of Allakos Inc is null.

What do analysts say about Allakos Inc?
Collapse

According to the analysts Allakos Inc is considered a hold.